9,051
Views
0
CrossRef citations to date
0
Altmetric
Review

Management of Chronic Non-Cancer Pain: a Framework

ORCID Icon &
Pages 751-777 | Received 26 Jan 2022, Accepted 13 May 2022, Published online: 01 Jun 2022

References

  • Dowell D , HaegerichT , ChouR. CDC guideline for prescribing opioids for chronic pain – United States, 2016. MMWR65, 1–49 (2016).
  • Nadeau SE , WuJK , LawhernRA. Opioids and chronic pain: an analytic review of the clinical evidence. Front. Pain. Res.2, 721357 (2021).
  • Mattson CL , TanzLJ , QuinnK , KariisaM , PatelP , DavisNL. Trends and geographic patterns in drug and synthetic opioid overdose deaths – United States, 2013–2019. MMWR70(6), 202–207 (2021).
  • Provisional Drug Overdose Deaths. https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm
  • Szalavitz M , RiggKK , WakemanSE. Drug dependence is not addiction – and it matters. Ann. Med.53(1), 1989–1992 (2021).
  • Fishbain DA , ColeB , LewisJ , RosomoffHL , RosomofRS. What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review. Pain Med.9, 445–459 (2008).
  • Han B , ComptonWM , BiancoC , CraneE , LeeJD , JonesCM. Prescription opioid use, misuse, and use disorders in U.S. adults: 2015 National Survey on Drug Use and Health. Ann. Int. Med.167, 293–301 (2017).
  • Hellman D . Prosecuting doctors for trusting patients. George Mason Law Rev.16, 735–777 (2009).
  • Van Boekel LC , BrouwersEPM , Van WeeghelJ , GarretsenHFL. Stigma among health professions toward patients with substance use disorders and its consequences for healthcare delivers: systematic review. Drug Alcohol Dep.131(1–2), 23–35 (2013).
  • Hari J . Chasing the Scream. The First and Last Days of the War on Drugs. Bloomsbury Publishing, NY, USA (2015).
  • Minhee C , CalandrilloS. The cure for America’s opioid crisis? End the war on drugs. Harvard J. Law. Publ. Pol.42, 547–623 (2019).
  • Cicero TJ , KurtzSP , SurrattHLet al. Multiple determinants of specific modes of prescription opioid diversion. J. Drug Issues41(2), 283–304 (2011).
  • Walker MJ , WebsterLR. Risk factors for drug diversion in a pain clinic patient population. J. Opioid Manag.8(6), 351–362 (2012).
  • Drug Enforcement Administration . Diversion Control Division. Proposed aggregate production quotas for schedule I and II controlled substances and assessment of annual needs for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine for 2020. Federal Register177, 48170–48177 (2019).
  • Kay C , WozniakE , ChingA , BernsteinJ. Pain agreements and healthcare utilization in a Veterans Affairs primary care population: a retrospective chart review. Pain. Ther.7, 121–126 (2018).
  • Argoff CE , AlfordDP , FudinJet al. Rational urine drug monitoring in patients receiving opioids for chronic pain: consensus recommendations. Pain Med.19(1), 97–117 (2018).
  • Saitman A , ParkH-D , FitzgeraldRL. False-positive interferences of common urine drug screen immunoassays: a review. J. Analyt. Toxicol.38, 387–396 (2014).
  • Oliva JD . Dosing discrimination: regulating PDMP risk scores. Calif. Law. Rev.110, 47–115 (2022).
  • Centers for Disease Control and Prevention . U.S. prescribing rate maps. https://www.cdc.gov/drugoverdose/maps/rxrate-maps.html (2017).
  • Higham S , HorwitzS , RichS. 76 billion opioid pills: newly released federal data unmasks the epidemic. The Washington Post, DC, USA (2019). https://www.washingtonpost.com/investigations/76-billion-opioid-pills-newly-released-federal-data-unmasks-the-epidemic/2019/07/16/5f29fd62-a73e-11e9-86dd-d7f0e60391e9_story.html
  • Compton WM , JonesCM , BaldwinGT. Relationship between nonmedical prescription-opioid use and heroin use. N. Engl. J. Med.374, 154–163 (2016).
  • Rose ME . Are prescription opioids driving the opioid crisis? Assumptions vs facts. Pain Med.19, 793–807 (2018).
  • Schatman ME , ZieglerSJ. Pain management, prescription opioid mortality, and the CDC: is the devil in the data?J. Pain Res.10, 2489–2495 (2017).
  • Dasgupta N , BeletskyL , CiccaroneD. Opioid crisis: no easy fix to its social and economic determinants. Am. J. Pub. Health108, 182–186 (2018).
  • Singer JA , SullumJZ , SchatmanME. Today’s nonmedical opioid users are not yesterday’s patients; implications of data indicating stable rates of nonmedical use and pain reliever use disorder. J. Pain Res.12, 617–620 (2019).
  • Office of the Surgeon General . Facing Addiction in America. The Surgeon General’s Report on Alcohol, Drugs, and Health. U.S. Department of Health and Human Services, DC, USA (2016).
  • Alpert A , PowellD , PaculaR. Supply-side drug policy in the presence of substitutes: evidence from the introduction of abuse-deterent opioids (Working Paper 23031). National Bureau of Economics Research, DC, USA (2017). http://www.nber.org/papers/w23031 ( archived by WebCite athttp://www.webcitation.org/70OhacSIK)
  • Rutkow L , VernickJS , AlexanderGC. More states should regulate pain management clinics to promote public health. AJPH107(2), 240–243 (2017).
  • The Heller School for Social Policy and Management . History of prescription drug monitoring programs. Brandeis University, MA, USA (2018).
  • Finley EP , GarciaAM , RosenK , McgearyD , PughMJ , PotterJS. Evaluating the impact of prescription drug monitoring program implementation: a scoping review. BMC Health Services Res.17, 420 (2017).
  • Gugelmann H , PerroneJ , NelsonL. Windmills and pill mills: can PDMPs tilt the prescription drug epidemic?J. Med. Toxicol.8, 378–386 (2012).
  • Ansari B , ToteKM , RosenbergES , MartinEG. A rapid review of the impact of systems-level policies and interventions on population-level outcomes related to the opioid epidemic, United States and Canada. Pub. Health Rep.135(Suppl. 1), S100–S127 (2020).
  • Lee B , ZhaoW , YangK-C , AhnY-Y , PerryBL. Systematic evaluation of state policy interventions targeting the US opioid epidemic, 2007–2018. JAMA Open4(2), e20366871–14 (2021).
  • CDC.CDC Clinical Practice Guideline for Prescribing Opioids – United States (2022) . https://static1.squarespace.com/static/54d50ceee4b05797b34869cf/t/6205252bfddc35678ff42b18/1644504366674/CDC-2022-0024-0002_content.pdf?fbclid=IwAR0_2atY0jNOxV5E_D7dJ4Gt6oKj4qYSh9xBUce4y-BpZUnZcdXr7DvoN4Y
  • Shaw WS , NelsonCC , WoiszwilloMJ , GainesB , PetersSE. Early return to work has benefits for relief of back pain and functional recovery after controlling for multiple confounds. J. Occup. Environ. Med.60(10), 901–910 (2018).
  • Krebs EE , LorenzKA , BairMJet al. Development and initial validation of the PEG, a three-item scale assessing pain intensity and interference. J. Gen. Intern. Med.24(6), 733–738 (2009).
  • Breivik H , BorchgrevinkPC , AllenSMet al. Assessment of pain. Br. J. Anaesth.101, 17–24 (2008).
  • Kim J , LeeKS , KongSWet al. Correlations between electrically quantified pain degree, subjectively assessed visual analogue scale, and the McGill Pain Questionnaire: a pilot study. Ann. Rehab. Med.38, 665–672 (2014).
  • Nadeau SE , DelroccoNJ , WuSS. Opioid trials: time for a new approach. Enriched enrollment randomized gradual withdrawal designs. Pain. Manag. doi:10.2217/pmt-2021-0112 (2022).
  • Gudin JA . Assessment of extended-release opioid analgesics for the treatment of chronic pain. J. Pain Palliat. Care Pharmacother.27, 49–61 (2013).
  • Jones CM , PaulozziLJ , MackKA. Alcohol involvement in opioid pain reliever and benzodiazepine drug abuse-related emergency department visits and drug-related deaths – United States, 2010. MMWR63(40), 881–885 (2014).
  • Shiue KY , AustinAE , ProescholdbellS , CoxME , AureliusM , NaumannRB. Literal text analysis of poly-class and polydrug overdose deaths in North Carolina, 2015–2019. Drug Alcohol. Depend.228, 109048 1–5 (2021).
  • Figgatt MC , AustinAE , CoxME , ProescholdbellS , MarshallSW , NaumannRB. Trends in unintentional polysubstance overdose deaths and individual and community correlates of polysubstance abuse, North Carolina, 2009–2018. Drug Alcohol Depend.219, 108504 1–710.1016/j.drugalcdep.2020.108504 (2021).
  • Braden JB , SullivanMD , RayGTet al. Trends in long-term opioid therapy for noncancer pain among people with a history of depression. Gen. Hosp. Psychiatry31, 564–570 (2009).
  • Banks S , KernsR. Explaining high rates of depression in chronic pain: a diathesis-stress framework. Psychol. Bull.119, 95–110 (1996).
  • De Heer EW , TenHave M , Van MarwijkHWJet al. Pain as a risk factor for common mental disorders. Results from the Netherlands Mental Health Survey and Incidence Study-2: a longitudinal, population-based study. Pain159, 712–718 (2018).
  • Mitchell AJ , VazeA , RaoS. Clinical diagnosis of depression in primary care: a meta-analysis. Lancet374, 609–619 (2009).
  • Braden JB , RussoJ , FanM-Yet al. Emergency department visits among recipients of chronic opioid therapy. Arch. Intern. Med.170, 1425–1432 (2010).
  • Dunn KM , SaundersKW , RutterCMet al. Opioid prescriptions for chronic pain and overdose. Ann. Intern. Med.152, 85–92 (2010).
  • Craven MA , BlandR. Depression in primary care: current and future challenges. Canad. J. Psychiatry.58, 442–448 (2013).
  • MD+CALC.PHQ-9 (Patient Health Questionnaire-9) . https://www.mdcalc.com/phq-9-patient-health-questionnaire-9
  • Negeri ZF , LevisB , SunYet al. Accuracy of the Patient Health Questionnaire-9 for screening to detect major depression: updated systematic review and individual participant data meta-analysis. BMJ274, n2183 (2021).
  • Barth J , MunderT , GergerHet al. Comparative efficacy of seven psychotherapeutic interventions for patients with depression: a network meta-analysis. PLoS Med.10(5), e1001454 (2013).
  • Cohen MJM , MenefeeLA , DoghramjiK , AndersonWR , FrankED. Sleep in chronic pain: problems and treatments. Int. Rev. Psych.12, 115–127 (2000).
  • Pilowsky I , CrettendenI , TownleyM. Sleep disturbance in pain clinic patients. Pain23, 27–33 (1985).
  • Mork PJ , VikKL , MoeB , LierR , BardalEM. Sleep problems, exercise and obesity and risk of chronic musculoskeletal pain: the Norwegian HUNT study. Eur. J. Pub. Health24(6), 924–929 (2013).
  • Roehrs T , RothT. Sleep and pain: interaction of two vital functions. Semin. Neurol.25(1), 106–116 (2005).
  • Koffel E , KroenkeK , BairMJ , LevertyD , PolusnyMA , KrebsEE. The bidirectional relationship between sleep complaints and pain: analysis of data from a randomized trial. Health Psychol.35(1), 41–49 (2016).
  • Koffel E , KatsAM , KroenkeKet al. Sleep disturbance predicts less improvement in pain outcomes: secondary analysis of the SPACE randomized clinical trial. Pain Med.21(6), 1162–1167 (2020).
  • Heffner KL , FranceCR , AshrafiounLet al. Clinical pain-related outcomes and inflammatory cytokine responses to pain following insomnia improvement in adults with knee osteoarthritis. Clin. J. Pain34, 1133–1140 (2018).
  • Manconi M , Garcia-BorregueroD , SchormairBet al. Restless legs syndrome. Nat. Rev. Dis. Primers.7(1), 80 (2021).
  • Rios P , CardosoR , MorraDet al. Comparative effectiveness and safety of pharmacological and non-pharmacological interventions for insomnia: an overview of reviews. Syst. Rev.8(281), 1–16 (2019).
  • Rosenberg R , CitromeL , DrakeCL. Advances in the treatment of chronic insomnia: a narrative review of new nonpharmacologic and pharmacologic therapies. Neuropsychiatr. Dis. Treat.17, 2549–2566 (2021).
  • Boness CL , HershenbergR , KayeJet al. An evaluation of cognitive behavioral therapy for insomnia: a systematic review and application of Tolin’s criteria for empirically supported treatments. Clin. Psychol.27(4), 1–25 (2020).
  • Jaffer KY , ChangT , VanleBet al. Trazodone for insomnia: a systematic review. Innov Clin. Neurosci.14, 24–34 (2017).
  • Nadeau SE , BehrmanAL , DavisSEet al. Donepezil: possibly effective adjuvant to constraint induced therapy for upper extremity dysfunction after stroke. J. Rehab. Res. Dev.41, 525–535 (2004).
  • Van Heck O , AustinSK , KhanRA , SmithBH , TorranceN. Neuropathic pain in the general population: a systematic review of epidemiological studies. Pain144, 654–662 (2014).
  • Da Costa BR , PereiraTV , SaadatPet al. Effectiveness and safety of non-steroidal anti-inflammatory drugs and opioid treatment for knee and hip osteoarthritis: network meta-analysis. BMJ375, n2321 (2021).
  • Mcdonagh MS , SelphSS , BuckleyDIet al. Nonopioid pharmacologic treatments for chronic pain. Comparative Effectiveness Review No. 228. AHRQ Publication No. 20-EHC010 doi:10.23970/AHRQEPCCER228 (2018).
  • Chou R , DeyoR , FriedlyJet al. Systemic pharmacological therapies for low back pain: a systematic review for an American College of Physicians clinical practice guideline. Ann. Intern. Med.166(7), 480–492 (2017).
  • Zaringhalam J , ManahejiH , RastqarA , ZaringhalamM. Reduction of chronic non-specific low back pain: a randomised controlled clinical trial on acupuncture and baclofen. Chin. Med.5(15), 1–7 (2010).
  • Enke O , NewHA , NewCHet al. Anticonvulsants in the treatment of low back pain and lumbar radicular pain: a systematic review and meta-analysis. CMAJ190, E786–E793 (2018).
  • Wiffen PJ , DerryS , BellBet al. Gapentin for chronic neuropathic pain in adults. Cochrane Database Syst. Rev.6, CD007938 (2017).
  • Derry S , StraubeS , WiffenPJ , AldingtonD , MooreRA. Pregabalin for neuropathic pain in adults. Cochrane Database Syst. Rev. 1, CD007076 (2019).
  • Price R , SmithD , FranklinGet al. Oral and topical treatment of painful diabetic polyneuropathy: practice guideline update summary. Report of the AAN Guideline Subcommittee. Neurology98, 31–43 (2021).
  • Iqbal Z , AzmiS , YadavRet al. Diabetic peripheral neuropathy: epidemiology, diagnosis, and pharmacotherapy. Clin. Ther.40, 828–849 (2018).
  • Abou-Raya S , Abou-RayaA , HelmiiM. Duloxetine for the management of pain in older adults with knee osteoarthritis: randomised placebo-controlled trial. Age Aging41, 646–652 (2012).
  • Chappell AS , OssannaMJ , Liu-SeifertHet al. Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: a 13-week, randomized, placebo-controlled trial. Pain146, 253–260 (2009).
  • Goldstein DJ , LuY , DetkeMJ , HudsonJ , IyengarS , DemitrackMA. Effects of duloxetine on painful physical symptoms associated with depression. Psychosomatics45, 17–28 (2004).
  • Baron R , MayoralV , LeijonG , BinderA , SteigerwaldI , SerpellM. 5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-state RCT study. Cur. Med. Res. Opin.25(7), 1663–1676 (2009).
  • Buksnys T , ArmstrongN , WorthyGet al. Systematic review and network meta-analysis of the efficacy and safety of lidocaine 700 mg medicated plaster vs. pregabalin. Cur. Med. Res. Opin.36(1), 101–115 (2020).
  • Sommer C , KloseP , WelschP , PetzkeF , HäuserW. Opioids for chronic non-cancer neuropathic pain. An updated systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration. Eur. J. Pain.24, 3–18 (2020).
  • Peckam AM , FairmanKA , SclarDA. All-cause and drug-related medical events associated with overuse of gabapentin and/or opioid medications: a retrospective cohort analysis of a commercially insured US population. Drug Saf.41, 213–228 (2018).
  • Gomes T , JuurlinkDN , AntoniouT , MamdaniMM , PatersonJM , VanDen Brink W. Gabapentin, opioids, and the risk of opioid-related death: a population-based nested case control study. PLoS Med.14(10), e1002396 (2017).
  • Cruccu G , DiStefano G , TruiniA. Trigeminal neuralgia. N. Engl. J. Med.383, 754–762 (2020).
  • Bendtsen L , ZakrzewskaJM , HeinskouTBet al. Advances in diagnosis, classification, pathophysiology and management of trigeminal neuralgia. Lancet Neurol.18, 784–796 (2020).
  • Eriksson M , Ben-ManachemE , AndersenO. Epileptic seizures, cranial neuralgias and paroxysmal symptoms in remiting and progressive multiple sclerosis. Mult. Scler.8, 495–499 (2002).
  • Di Stefano G , TruiniA , CruccuG. Current and innovative pharmacological options to treat typical and atypical trigeminal neuralgia. Drugs78, 1433–1442 (2018).
  • Adamo D , CoppolaN , PecoraroG , NicoloM , MignognaMD. Lacosamide in trigeminal neuralgia: report of a case refractory to first- and second-generation anticonvulsants. Cranio. doi:10.1080/08869634.2020.1804233 1-5 (2020).
  • Sidon E , RogeroR , McdonaldEet al. Prevalence of neuropathic pain symptoms in foot and ankle patients. Foot & Ankle Int.40(6), 629–633 (2019).
  • Halker Singh RB , VanderpluymJH , MorrowASet al. Acute treatments for episodic migraine. Comparative effectiverness review No. 239. AHRQ Publication No. 21-EHC009 doi:10.23970/AHRQEPCCER239 (2020).
  • Vanderpluym JH , HalkerSingh RB , UrtechoMet al. Acute treatments for episodic migraine in adults. A systematic review and meta-analysis. J. Am. Med. Assoc.325(23), 2357–2369 (2021).
  • Hepp Z , BloudekLM , VaronSF. Systematic review of migraine prophylaxis adherence and persistence. J. Manag. Care Pharm.20(1), 22–33 (2014).
  • Hepp Z , DodickDW , VaronSF , GillardP , HansenRN , DevineEB. Adherence to oral migraine-preventive medications among patients with chronic migraine. Cephalalgia35(6), 478–488 (2015).
  • Orlando V , MucherinoS , MonettiVM , TramaU , MendittoE. Treatment patterns and medication adherence among newly diagnosed patients with migraine: a drug utilisation study. BMJ Open10, e038972 (2020).
  • Ferarri MD , GoadsbyPJ , BursteinRet al. Migraine. Nat. Rev. Dis. Primers.8(2), 1–20 (2022).
  • Ray JC , HuttonEJ , MatharuM. OnabotulinumtoxinA in migraine: a review of the literature and factors associated with efficacy. J. Clin. Med.10 (2021).
  • Takeda M , TanimotoT , IkedaM , KadoiJ , NasumM , MatsumotoS. Opioidergic modulation of excitability of rate trigeminal root ganglion neuron projections to the superficial layer of the cervical dorsal horn. Neuroscience125(4), 995–1008 (2004).
  • Berg KA , ZardenetaG , HargreavesKM , ClarkeWP , MilamSB. Integrins regulate opioid receptor signaling in trigeminal ganglion neurons. Neurosci.144(3), 889–897 (2007).
  • Patwardhan AM , BergKA , AkopainANet al. Bradykinin-induced functional competence and trafficking of the delta-opioid receptor in trigeminal nociceptors. J. Neurosci.25(39), 8825–8832 (2005).
  • Loder E , WeizenbaumE , FrishbergB , SilversteinS. Force. AHSCWT. Choosing wisely in headache medicine: the American Headache Society’s list of five things physicians and patients should question. Headache53, 1651–1659 (2013).
  • Bohnert ASB , ValensteinM , BairMJet al. Association between opioid prescribing patterns and opioid overdose-related deaths. J. Am. Med. Assoc.305, 1315–1321 (2011).
  • Gomes T , JuurlinkDN , DhallaIA , Mailis-GagnonA , PatersonJM , MamdaniMM. Trends in opioid use and dosing among socio-economically disadvantaged patients. Open Med.5, 13–22 (2011).
  • Abbasi AB , Salisbury-AfsharE , BerberetCW , LaydenJE , PhoMT. Opioid prescribing patterns before fatal opioid overdose. Am. J. Prevent. Med.58, 250–253 (2020).
  • Massachusetts Department of Public Health . An assessment of opioid-related deaths in Massachusetts (2013–2014). (2016).
  • Patel MR , MahaffeyKW , GargJet al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N. Engl. J. Med.365, 883–891 (2011).
  • The Task Force for the Diagnosis and Management of Atrial Fibrillation of the European Society of Cardiology (Esc) . 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur. Heart J.42(5), 373–498 (2021).
  • Friberg L , RosenqvistM , LipGYH. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182,678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. Eur. Heart J.33, 1500–1510 (2012).
  • Kotlinska-Lemieszek A , ZyliczZ. Less well-known consequences of the long-term use of opioid analgesics: a comprehensive literature review. Drug Des. Devel. Ther.16, 251–264 (2022).
  • Deyo RA , SmithDHM , JohnsonESet al. Prescription opioids for back pain and use of medications for erectile dysfunction. Spine38(11), 909–915 (2013).
  • Rubinstein AL , CarpenterDM. Association between commonly prescribed opioids and androgen deficiency in men: a retrospective cohort analysis. Pain Med.18, 637–644 (2017).
  • Richardson E , BedsonJ , ChenY , LaceyR , DunnKM. Increased risk of reproductive dysfunction in women prescribed long-term opioids for musculoskeletal pain: a matched cohort study in the Clinical Practive Research Datalink. Eur. J. Pain22, 1701–1708 (2018).
  • Bedson J , ChenY , AshworthJ , HaywardRA , DunnKM , JordanKP. Risk of adverse events in patients prescribed long-term opioids: a cohort study in the UK Clinical Practice Research Datalink. Eur. J. Pain23, 908–922 (2019).
  • Krebs EE , PaudelM , TaylorBCet al. Association of opioids with falls, fractures, and physical performance among older men with persistent musculoskeletal pain. J. Gen. Intern. Med.31(5), 463–469 (2016).
  • Lo-Ciganic W-H , FlodenL , LeeJKet al. Analgesic use and risk of recurrent falls in participants with or at risk of knee osteoarthritis: data from the Osteoorthritis Initiative. Osteoarthr. Cartil. Open.25, 1390–1398 (2017).
  • Taipale H , HaminaA , KarttunenNet al. Incident opioid use and risk of hip fracture among persons with Alzheimer’s disease: a nationwide matched cohort study. Pain160(2), 417–423 (2019).
  • Ping F , WangY , WangJ , ChenJ , ZhangW , ZhiH. Opioids increase hip fracture risk: a meta-analysis. J. Bone Min. Metab.35, 289–297 (2017).
  • Carman WJ , SuS , CookSF , WurzelmannJI , McafeeA. Coronary heart disease outcomes among chronic opioid and cyclooxygernase-2 users compared with a general population cohort. Pharmacoepidemiol. Drug Saf.20, 754–762 (2011).
  • Li L , SetoguchiS , CabralH , JickS. Opioid use for noncancer pain and risk of myocardial infarction among adults. J. Intern. Med.273, 511–526 (2013).
  • Ray WA , ChungCP , MurrayKT , HallK , SteinCM. Prescription of long-acting opioids and mortality in patients with chronic noncancer pain. J. Am. Med. Assoc.315, 2415–2423 (2016).
  • Davis MP , BehmB , BalachandranD. Looking both ways before crossing the street: assessing the benefits and risks of opioids in treating patients at risk of sleep disordered breathing for pain and dyspnea. J. Opioid Manag.13(3), 10.5055/jom.2017.0385 (2017).
  • Vozoris NT , WangX , FischerHDet al. Incident opioid drug use and adverse respiratory outcomes among older adults with COPD. Eur. Resp. J.48, 683–693 (2016).
  • Nadpara PA , JoyceAR , MurrelleELet al. Risk factors for serious prescription opioid-induced respiratory depression or overdose: comparison of commercially insured and Veterans Health Affairs populations. Pain Med.19, 79–96 (2018).
  • Zedler B , XieL , WangLet al. Risk factors for serious prescription opioid-related toxicity or overdose among Veterans Health Administration patients. Pain Med.15, 1911–1929 (2014).
  • Cowley NJ , OwenA , BionJF. Interpreting arterial blood gas results. BMJ346(f16), 10.1136/bmj.f16 (2013).
  • Hale ME , AhdiehH , MaT , RauckR; Oxymorphone ER Study Group 1. Efficacy and safety of OPANA ER (oxymorphone extended release) for relief of moderate to severe low back pain in opioid-experienced patients: a 12-week, randomized, double-blind, placebo-controlled study. J. Pain8, 175–184 (2007).
  • Katz N , RauckR , AhdiehH , GerritsenVan Der Hoop R , KerwinR , PodolskyG. A 12-week, randomized, placebo-controlled trial assessing the safety and efficacy of oxymorphone extended release for opioid-naive patients with chronic low back pain. Cur. Med. Res. Opin.23, 117–128 (2007).
  • Beeton AG , UptonPM , ShiptonEA. The case for patient-controlled analgesia. S. Afr. J. Surg.30, 5–6 (1992).
  • Cepeda MS , CarrDB. Women experience more pain and require more morphine than men to achieve a similar degree of analgesia. Anesth. Analg.97, 1464–1468 (2003).
  • Leitao MM , MalhotraV , BriscoeGet al. Postoperative pain medication requirements in patients undergoing computer-assisted (“robotic”) and standard laparoscopic procedures for newly diagnosed endometrial cancer. Ann. Surg. Oncol.20, 3561–3567 (2013).
  • Okutomi T , SaitoM , MochizukiJ , AmanoK , HokaS. A double-blind randomized controlled trial of patient-controlled epidural analgesia with or without a background infusion following initial spinal analgesia for labor pain. Int. J. Obstet. Anesth.18, 28–32 (2009).
  • Weissman DE , HaddoxJD. Opioid pseudo-addiction – an iatrogenic syndrome. Pain36, 363–366 (1989).
  • Cherny N , RipamontiC , PereiraJet al. Strategies to manage the adverse effects of oral morphine: an evidence-based report. J. Clin. Oncol.19, 2542–2554 (2001).
  • Quang-Cantagrel N , WallaceMS , MagnusonSK. Opioid substitution to improve the effectiveness of chronic noncancer pain control: a chart review. Anesth. Analg.90, 933–937 (2000).
  • Von Korff M , SaundersK , RayGTet al. De facto long-term opioid therapy for noncancer pain. Clin. J. Pain24, 521–527 (2008).
  • Rauck RL , NalamachuS , WildJEet al. Single-entity hydrocodone extended-release capsules in opioid-tolerant subjects with moderate-to-severe chronic low back pain: a randomized double-blind, placebo-controlled study. Pain Med.15, 975–985 (2014).
  • Schneider JP , AndersonA , TennantF. Patients who require ultra-high opioid doses. Pract. Pain Manag.9(7), (2009).
  • Lawhern RA , NadeauSE. Commentary: how to fill the holes in the CDC opioid prescribing guideline revisions. Pract. Pain Manag.21(6), (2021).
  • Nadeau SE . Opioids for chronic nonmalignant pain. To prescribe or not to prescribe – what is the question?Neurology85, 646–651 (2015).
  • Banta-Green C , CoffinPO , MerrillJOet al. Impacts of an opioid overdose prevention intervention delivered subsequent to acute care. Inj. Prev.25(3), 191–198 (2019).
  • Davis MP , PasternakG , BehmB. Treating chronic pain: an overview of clinical studies centered on the buprenorphine option. Drugs78, 1211–1218 (2018).
  • Boya C , BansalD , KanakagiriS , BhaiB. Efficacy and safety of opioid analgesices for the management of chronic low back pain: an evidence from Bayesian network meta-analysis. Pain Phys.24, 73–82 (2021).
  • Lazaridou A , PaschaliM , EdwardsRR , GilliganG. Is buprenorphine effective for chronic pain? A systematic review and meta-analysis. Pain Med.21(12), 3691–3699 (2020).
  • Pergolizzi JV , RaffaRB. Safety and efficacy of the unique opioid buprenorphine for the treatment of chronic pain. J. Pain Res.12, 3299–3317 (2019).
  • Steiner D , MuneraC , HaleME , RipaS , LaundaC. Efficacy and safety of buprenorphine transdermal system (BTDS) for chronic moderate to severe low back pain: a randomized, double-blind study. J. Pain12(11), 1163–1173 (2011).
  • Widenka M , LeppertW. Assessment of analgesic effects of different initial doses of transdermal buprenorphine in the treatment of chronic pain in the elderly diagnosed with osteoarthritis. J. Physiol. Pharmacol.71(5), 739–748 (2020).
  • Milligan K , Lanteri-MinetM , BorchertKet al. Evaluation of long-term efficacy and safety of transdermal fentanyl in the treatment of chronic noncancer pain. J. Pain2, 197–204 (2001).
  • Mystakidou K , ParpaE , TsilikaEet al. Long-term management of noncancer pain with transdermal therapeutic system-fentanyl. J. Pain4, 298–306 (2003).
  • Portenoy RK , FarrarJT , BackonjaM-Met al. Long-term use of controlled-release oxycodone for noncancer pain: results of a 3-year registry study. Clin. J. Pain23, 287–299 (2007).
  • Roth SH , FleischmannRM , BurchFXet al. Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain. Arch. Intern. Med.160, 853–860 (2000).
  • Volkow ND , MclellanAT. Opioid abuse in chronic pain – misconceptions and mitigation strategies. N. Engl. J. Med.374, 1253–1263 (2016).
  • Stead LF , PereraR , BullenCet al. Nicotine replacement therapy for smoking cessation (review). Cochrane Database Syst. Rev. doi:10.1002/14651858.CD000146.pub4.(11) (2012).
  • Winkelman TNA , ChangVW , BinswangerIA. Health, polysubstance use, and criminal justice involvement among adults with varying levels of opioid use. JAMA Network Open1(3), e180558 (2018).
  • Case A , DeatonA. Rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century. Proc. Natl Acad. Sci. USA112(49), 15078–15083 (2015).
  • Raz S , BergerBD. Social isolation increases morphine intake: behavioral and psychopharmacological aspects. Behav. Pharmacol.21, 39–46 (2010).
  • Alexander BK , BeyersteinBL , HadawayPF , CoambsRB. Effects of early and later colony housing on oral ingestion of morphine in rate. Pharmacol. Biochem. Behav.15(4), 571–576 (1981).
  • Roeckel L-A , LeCoz G-M , Gavériaux-RuffC , SimoninF. Opioid-induced hyperalgesia: cellular and molecular mechanisms. Neurosci.338, 160–182 (2016).
  • Gerum M , SimoninF. Behavioral characterization, potential clinical relevance, and mechanisms of latent pain sensitization. Pharmacol. Ther. doi:10.1016/j.pharmthera.2021.108032 (2021).
  • Fishbain DA , PulikalA. Does opioid tapering in chroniuc pain patients result in improved pain or same pain vs increased pain at taper completion? A structured evidence-based systematic review. Pain Med.20(11), 2179–2197 (2019).
  • Higgins C , SmithBH , MatthewsK. Evidence of opioid-induced hyperalgesia in clinical populations after chronic opioid exposure: a systematic review and meta-analysis. Br. J. Anesth.122(6), e114–e126 (2019).
  • Twillman RK , HemmenwayN , PassikSD , ThompsonCA , ShrumM , DegeorgeMK. Impact of opioid dose reduction on individuals with chronic pain: results of an online survey. J. Pain Res.11, 2769–2779 (2018).
  • Hallvik SE , ElIbrahimi S , JohnstonKet al. Patient outcomes after opioid dose reduction among patients with chronic opioid therapy. Pain163(1), 83–90 (2022).
  • Oliva EM , BoweT , ManhapraAet al. Associations between stopping prescriptions for opioids, length of opioid treatment, and overdose or suicide deaths in US veterans: observational evaluation. BMJ368, m283 (2020).
  • Mackey K , AndersonJ , BourneD , ChenE , PetersonK. Benefits and harms of long-term opioid dose reduction of discontinuation in patients with chronic pain: a rapid review. J. Gen. Intern. Med.35(Suppl. 3), S935–S944 (2020).
  • Frank JW , LovejoyTI , BeckerWCet al. Patient outcomes in dose reduction or discontinuation of long-term opioid therapy. A systematic review. Ann. Intern. Med.67, 181–191 (2017).
  • Moore RA , DerryS , TaylorRS , StraubeS , PhillipsCJ. The costs and consequences of adequately managed chronic non-cancer pain and chronic neuropathic pain. Pain Pract.14, 79–94 (2014).
  • Bandelow B , ReittM , RöverC , MichaelisS , GörlichY , WedekindD. Efficacy of treatments for anxiety disorders: a meta-analysis. Int. Clin. Psychopharmacol.30, 183–192 (2015).
  • Gerlach LB , WiechersIR , MaustDT. Prescription benzodiazepine use among older adults: a critical review. Harv. Rev. Psychiatry26(5), 264–273 (2018).
  • Heilman KM , NadeauSE. Emotional and neuropsychiatric disorders associated with Alzheimer’s disease. Neurotherapeutics10.1007/s13311-021-01172-w (2022).
  • Fick DM , CooperJW , WadeWE , WallerJL , MacleanJR , BeersMH. Updating the Beers criteria for potentially inappopriate medication use in older adults. Arch. Intern. Med.163, 2716–2724 (2003).
  • 2019 American Geriatrics Society Beers Criteria® Update Expert Panel . American Geriatrics Society 2019 updated AGS Beers criteria for potential inappropriate medication use in older adults. J. Am. Geriat. Soc.67, 674–694 (2019).
  • Defrancesco M , MarksteinerJ , FleischhackerWW , BlaskoI. Use of benzodiazepines in Alzheimer’s disease: a systematic review of literature. Int. J. Neuropsychopharmacol. doi:10.1093/ijnp/pyv055 1-11 (2015).
  • Collins R , ReithC , EmbersonJet al. Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet388, 2532–2561 (2016).
  • Zhao Y , LindB , StibranyJ. Risk factors for falls in homebound community-dwelling older adults. Pub. Health Nurs.36, 772–778 (2019).
  • Öztürk GB , KiliçC , BozkurtME , KaranMA. Prevalence and associates of fear of falling among communiuty-dwelling older adults. J. Nutr. Health Aging24(4), 433–439 (2021).
  • Sitdhiraksa N , PiyamongkolP , ChaiyawatPet al. Prevalence and factors associated with fear of falling in community-dwelling Thai elderly. Gerontol.67, 276–280 (2021).
  • Guina J , MerrillB. Benzodiazepines I: upping the care on downers: the evidence of risks, benefits and alternatives. J. Clin. Med.7(17), 1–22 (2018).
  • Smith DE , LandryMJ. Benzodiazepine dependency discontinuation: focus on the clinical dependency detoxification setting and benzodiazepine-polydrug abuse. J. Psychiatr. Res.24, 145–156 (1990).
  • Shader RI , GreenblattDJ. Use of benzodiazepines in anxiety disorders. N. Engl. J. Med.328, 1398–1405 (1993).
  • Park TW , SaitzR , GanoczyD , IlgenMA , BohnertASB. Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study. BMJ350, h2698 (2015).
  • Xu KY , HartzSM , BorodovskyJT , BierutLJ , GruczaRA. Association between benzodiazepine use with or without opioid use and all-cause mortality in the United States, 1999–2015. JAMA Network Open3(12), e2028577 (2020).
  • Hernandez I , HeM , BrooksMM , ZhangY. Exposure-response association between concurrent opioid and benzodiazepine use and risk of opioid-related overdose in Medicare Part D beneficiaries. JAMA Network Open1(2), e180919 (2018).
  • Ralph SJ , EspinetAJ. Increased all-cause mortality by antipsychotic drugs: updated review and meta-analysis in dementia and general mental health care. J. Alz. Dis. Rep.2, 1–26 (2018).
  • Skelly AC , ChouR , DettoriJRet al. Noninvasive nonpharmacological treatment for chronic pain: a systematic review (AHRQ Publication No. 18-EHC013-EF). (2018).
  • Skelly AC , ChouR , DettoriJRet al. Noninvasive Nonpharmacological Treatment for ChronicPain: A Systematic Review Update. Comparative Effectiveness Review No. 227. AHRQ Publication no. 20-EHC009 doi:10.23970/AHRQEPCCER227 (2020).
  • Han L , GouletJL , SkandersonMet al. Evaluation of complementary and integrative health approaches among veterans with musculoskeletal pain using propensity score methods. Pain Med.20(1), 90–102 (2018).
  • Loeser JD , SchatmanME. Chronic pain management in medical education: a disastrous omission. Postgrad. Med.129, 332–335 (2017).
  • Irving G , NevesAL , Dambha-MillerHet al. International variations in primarty care physician consultation times: a systematic review of 67 countries. BMJ Open.7, e017902 (2017).
  • Institute of Medicine . Relieving Pain in America. A Blueprint for Transforming Prevention, Care, Education, and Research. National Academies Press, DC, USA (2011).
  • National Center for Injury Prevention and Control . Centers for Disease Control and Prevention. Annual Surveillance Report of Drug-Related Risks and Outcomes (2018). https://www.cdc.gov/drugoverdose/pdf/pubs/2018-cdc-drug-surveillance-report.pdf
  • CDC Wonder. https://wonder.cdc.gov/ucd-icd10.html
  • Kaliyaperumal S , WilsonK , AeffnerF , DeanC. Animal models of peripheral pain: biology review and application for drug discovery. Toxicol. Pathol.48(1), 202–219 (2014).
  • Pogatski-Zahn E , SegelckeD , ZahnP. Mechnisms of acute and chronic pain after surgery: update from findings in experimental animal models. Curr. Opin. Anaesthesiol.31, 575–585 (2018).
  • Mifflin KA , KerrBJ. The transition from acute to chronic pain: understanding how different biological systems interact. Can. J. Anaesth.61, 112–122 (2014).
  • Thompson JM , NeugebauerV. Cortico-limbic pain mechanisms. Neurosci. Lett.702, 15–23 (2019).
  • Chew LA , BellampalliSS , DustrudeET , KhannaR. Mining the NaV interactome: opportunities for chronic pain therapeutics. Biochem. Pharmacol.163, 9–20 (2019).
  • Renés Descart. Philosophical Essays and Correspondence. Ariew R (Ed.). Hackett Publishing Company, IN, USA (2000).
  • Sagan C . The Demon-Haunted World. Science as a Candle in the Dark. Ballantine Books, NY, USA (1996).
  • Avery N , McneilageAG , StanawayFet al. Efficacy of interventions to reduce long term opioid treatment for chronic non-cancer pain: systematic review and meta-analysis. BMJ377, e066375 (2022).